SIROQUINE Trademark

Trademark Overview


On Monday, December 6, 2021, a trademark application was filed for SIROQUINE with the United States Patent and Trademark Office. The USPTO has given the SIROQUINE trademark a serial number of 97157448. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, April 11, 2023. This trademark is owned by Beijing HebaBiz Biotechnology Co., Ltd. The SIROQUINE trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for the treatment of tumour diseases; Medicines for the treatment of hepatopathy diseases; medicinal drinks; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals
siroquine

General Information


Serial Number97157448
Word MarkSIROQUINE
Filing DateMonday, December 6, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, April 11, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the stylized wording "Siroquine".
Goods and ServicesMedicines for the treatment of tumour diseases; Medicines for the treatment of hepatopathy diseases; medicinal drinks; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals
Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe wording "Siroquine" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, December 11, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBeijing HebaBiz Biotechnology Co., Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBeijing N/A
CN

Trademark Events


Event DateEvent Description
Tuesday, April 11, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, April 11, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, April 11, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, September 21, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 21, 2022NON-FINAL ACTION E-MAILED
Wednesday, September 21, 2022NON-FINAL ACTION WRITTEN
Wednesday, September 14, 2022ASSIGNED TO EXAMINER
Saturday, December 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 9, 2021NEW APPLICATION ENTERED